HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
about
Automated recognition of cell phenotypes in histology images based on membrane- and nuclei-targeting biomarkers.Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridInter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretationInherited and acquired alterations in development of breast cancer.Cetuximab in non-small cell lung cancer.Reproducibility in the automated quantitative assessment of HER2/neu for breast cancerHER2-positive male breast cancer: an update.Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy.Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains.Computer Aided Semi-Automated Evaluation of HER2 Immunodetection--A Robust Solution for Supporting the Accuracy of Anti HER2 Therapy.HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics.Observer performance in the use of digital and optical microscopy for the interpretation of tissue-based biomarkers.
P2860
Q33297816-E5B317F3-7E68-45BD-9F51-CAA6CD882BF9Q33378811-219DD07C-BB64-446A-98D2-5B781FAD23B7Q33454999-A18E3B85-D458-4EC7-A32A-F7C78A5F5373Q34044859-663F9E04-398A-4840-B0D9-CA00A34E4F9DQ36925229-8FA04286-0290-4EF0-8E54-8F807C0128CDQ37032651-A24DAE26-5203-4550-A6A0-7775D40EB2A2Q37102555-ADFAC5E2-7948-47B4-B278-2F5122E19012Q37355586-1C504653-9822-45F3-A12A-4B49606C681BQ37699132-6FDB70F1-03DA-454E-956C-C0D2D95442C3Q37889274-91C4A63C-4FD7-48E7-AE0D-4936D7B54B98Q38822034-23A49C35-EA65-4C0E-B1FB-83228CE29BC0Q39980300-EFD05A46-029E-4FFE-889D-8A44AED9C04DQ40264759-9A1F8B61-F739-4668-8A68-0A7077F5606FQ46188099-F417C5D4-4DF8-48D8-93A3-28DBF6693F7DQ53167565-452C374F-CD97-4119-B2A7-CDC9D1564F64
P2860
HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
HER-2 status in breast cancer: ...... anced cellular imaging system.
@en
type
label
HER-2 status in breast cancer: ...... anced cellular imaging system.
@en
prefLabel
HER-2 status in breast cancer: ...... anced cellular imaging system.
@en
P2093
P1476
HER-2 status in breast cancer: ...... anced cellular imaging system.
@en
P2093
Armando Ciampa
Ashraf Khan
Daniel Baiyee
Gamze Ayata
Jan Wallace
Kathryn Edmiston
Michael Wertheimer
P304
P356
10.1097/01.PAI.0000150516.75567.13
P577
2006-06-01T00:00:00Z